INS and obesity disorder: Dysregulation of this signaling can lead to metabolic disorders such as diabetes, obesity, and insulin resistance syndromes.176 Understanding the details of insulin/IGF signaling pathways and their interactions is crucial for developing effective therapeutic interventions for these conditions.